Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Setastine Hydrochloride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101486687B details a low-toxicity synthesis of Setastine Hydrochloride using Xylene and PEG400, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.